Alpha Teknova (TKNO) Retained Earnings (2020 - 2026)
Alpha Teknova's (TKNO) quarterly Retained Earnings came in at $205.3 million in Q1 2026, up 266.65% year-on-year from $56.0 million in Q1 2025, and up 251.17% on a QoQ basis from -$135.8 million in Q4 2025.
Alpha Teknova (TKNO) Retained Earnings (2020 - 2026) Analysis & Trends
Alpha Teknova (TKNO) has 7 years of Retained Earnings data on file, last reported at $205.3 million in Q1 2026.
- On a quarterly basis, Retained Earnings rose 266.65% year-over-year to $205.3 million in Q1 2026; TTM through Mar 2026 was $205.3 million, a 266.65% increase from a year earlier, with the FY2025 full-year figure at -$135.8 million, down 167.58% from the prior year.
- Retained Earnings for Q1 2026 stood at $205.3 million, up from -$135.8 million in the prior quarter.
- Over the last five years, Retained Earnings for TKNO reached as high as $205.3 million in Q1 2026 and fell as low as -$135.8 million in Q4 2025.
- Historically, Retained Earnings has averaged $42.6 million across 5 years, with a median of -$19.2 million in 2022.
- On a YoY basis, Retained Earnings climbed as much as 2154.8% in 2022 and fell as far as 2905.94% in 2022.
- Year by year, Retained Earnings stood at $154.9 million in 2022, then tumbled by 159.26% to -$91.8 million in 2023, then surged by 318.9% to $200.9 million in 2024, then tumbled by 167.58% to -$135.8 million in 2025, then soared by 251.17% to $205.3 million in 2026.
- Per Business Quant data, the three most recent Retained Earnings figures were $205.3 million in Q1 2026, -$135.8 million in Q4 2025, and $203.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 37.04 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 28.20 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 1.11 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 4.54 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 8.83 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -1.81 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 18.66 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 589.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -2.13 Bn |
| 10 | Alpha Teknova | 278.75 Mn | 260.97 Mn | 3.78 Mn | 205.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 205.27 Mn |
| Dec 31, 2025 | -135.79 Mn |
| Sep 30, 2025 | 203.68 Mn |
| Jun 30, 2025 | 202.80 Mn |
| Mar 31, 2025 | -123.18 Mn |
| Dec 31, 2024 | 200.92 Mn |
| Sep 30, 2024 | -112.81 Mn |
| Jun 30, 2024 | 184.18 Mn |
| Mar 31, 2024 | -99.88 Mn |
| Dec 31, 2023 | -91.79 Mn |
| Sep 30, 2023 | 180.78 Mn |
| Jun 30, 2023 | -70.98 Mn |
| Mar 31, 2023 | -63.82 Mn |
| Dec 31, 2022 | 154.89 Mn |
| Sep 30, 2022 | -41.71 Mn |
| Jun 30, 2022 | -19.24 Mn |
| Mar 31, 2022 | 151.58 Mn |
| Dec 31, 2021 | -7.54 Mn |
| Sep 30, 2021 | 150.12 Mn |
| Jun 30, 2021 | -640,000.00 |